Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25556,896,0.98 [0.91-1.05],0.5169461799935454
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25597,143,0.99 [0.82-1.19],0.891273653533731
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27175,153,0.99 [0.83-1.19],0.9493675820470444
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20323,501,1.01 [0.92-1.12],0.8055849085154987
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27113,91,0.89 [0.70-1.12],0.3062621307128164
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26397,80,0.82 [0.64-1.06],0.1295962314252558
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28145,90,0.90 [0.71-1.13],0.3631755005364759
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28168,63,0.88 [0.67-1.16],0.3713592065741264
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,25831,45,1.19 [0.87-1.64],0.2741492982729183
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27627,106,0.93 [0.75-1.16],0.530779296699579
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27590,69,0.79 [0.60-1.03],0.0817568284703779
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28210,64,1.14 [0.88-1.49],0.3254157067406549
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28166,101,1.07 [0.87-1.33],0.5097918852984842
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28156,91,1.09 [0.87-1.36],0.4679956849851197
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Mycoses,27973,45,0.90 [0.65-1.25],0.5389901230956535
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27334,389,0.93 [0.83-1.04],0.2297743810351027
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27090,145,0.93 [0.78-1.12],0.4522637134778994
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27194,249,0.94 [0.82-1.08],0.4083696148780262
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24494,28,0.89 [0.59-1.35],0.5837541122432721
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24515,49,0.94 [0.68-1.28],0.6782851050489646
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24595,129,1.08 [0.89-1.31],0.4247412210436423
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24599,133,1.07 [0.88-1.29],0.5001651193874168
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13762,293,0.91 [0.80-1.04],0.1566193788295944
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11024,27,1.14 [0.76-1.72],0.5331002862845632
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24515,49,0.80 [0.58-1.11],0.1807823506214395
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26055,820,1.07 [0.99-1.16],0.0772762065332019
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27139,200,1.09 [0.94-1.27],0.2543019643041769
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27784,79,0.97 [0.76-1.24],0.8177781783436575
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28284,71,1.04 [0.81-1.35],0.7393678899566523
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Rectum,28045,48,1.34 [0.99-1.82],0.0550404825905942
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28289,38,0.84 [0.59-1.21],0.3606729651298543
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm: Stomach,28329,31,0.89 [0.60-1.32],0.5526187930650258
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm,28018,301,1.03 [0.90-1.16],0.6958104236212187
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28259,117,0.95 [0.78-1.16],0.6298646685137039
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28266,96,1.02 [0.82-1.28],0.8304810315537349
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28228,46,0.76 [0.54-1.06],0.1006246866196785
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,"Haemangioma, any site",28230,46,0.76 [0.54-1.06],0.1006109650248599
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi,28127,253,1.03 [0.90-1.18],0.6608113722469776
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28290,112,1.13 [0.92-1.38],0.2449840078454227
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Other benign neoplasms of skin,28197,191,1.00 [0.85-1.17],0.9772152170108448
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Benign neoplasm of breast,15623,93,0.96 [0.76-1.21],0.736932237067069
PPP1R2,Protein phosphatase inhibitor 2,Chapter II Neoplasms,Leiomyoma of uterus,15258,693,1.05 [0.96-1.14],0.2914359406967342
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27296,201,1.19 [1.03-1.39],0.0207947693438273
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27180,353,1.09 [0.97-1.22],0.1556232269600433
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27180,353,1.09 [0.97-1.22],0.1556232269600433
PPP1R2,Protein phosphatase inhibitor 2,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),25965,365,1.11 [0.99-1.24],0.0726178953501365
PPP1R2,Protein phosphatase inhibitor 2,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,27854,79,0.93 [0.73-1.19],0.569117732490429
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28060,107,1.12 [0.91-1.38],0.2875750143212705
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,24838,710,1.06 [0.97-1.15],0.1755300146873882
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27000,442,1.07 [0.96-1.19],0.2060830053961269
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26490,114,1.05 [0.86-1.29],0.6266373054969615
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27559,53,0.96 [0.71-1.30],0.7857967468811577
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26477,101,1.03 [0.83-1.27],0.7978930736595071
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26715,339,1.01 [0.89-1.14],0.8670566778614688
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26706,330,1.01 [0.90-1.15],0.8329318995962717
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26359,185,0.96 [0.80-1.14],0.6302762527170054
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26363,182,0.97 [0.81-1.16],0.725333434250256
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24673,545,1.03 [0.93-1.13],0.5669748698430778
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24201,73,0.94 [0.72-1.22],0.6176327759381055
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24628,500,1.03 [0.93-1.14],0.609838933306462
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24170,42,1.26 [0.91-1.74],0.1640199855704319
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24207,79,1.01 [0.79-1.30],0.919658106310983
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Any mental disorder,24582,770,1.01 [0.93-1.10],0.7456731992306433
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24107,295,0.96 [0.84-1.10],0.55202663233643
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27885,225,0.94 [0.81-1.09],0.4047824358326407
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27958,163,0.97 [0.81-1.15],0.7126113698115295
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26326,80,0.80 [0.62-1.03],0.0831237432642275
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28212,80,0.79 [0.62-1.02],0.0730577519452017
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",23892,80,0.80 [0.62-1.03],0.0777018605891397
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Alcohol dependence,26343,97,0.83 [0.66-1.05],0.1281422898454478
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Smoking dependency,26310,69,1.08 [0.82-1.42],0.5688580661958678
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",23884,72,0.87 [0.67-1.14],0.3103292728215833
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24203,391,1.02 [0.91-1.14],0.7318211360375553
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression,26577,338,1.03 [0.91-1.16],0.6254751862069573
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Depression or dysthymia,24052,296,1.04 [0.91-1.18],0.5764276626109794
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",23957,145,1.13 [0.95-1.36],0.1661536217388035
PPP1R2,Protein phosphatase inhibitor 2,Chapter V Mental and behavioural disorders,Other anxiety disorders,26803,68,0.97 [0.74-1.27],0.8274502626661191
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Neurological diseases,25189,1460,1.03 [0.97-1.10],0.2781522618996976
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23494,163,1.01 [0.85-1.20],0.893382792913063
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28124,133,1.07 [0.89-1.29],0.4754427992745578
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26964,497,1.00 [0.91-1.11],0.9219517689756572
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Epilepsy,26637,170,0.88 [0.74-1.04],0.1458499536204254
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Migraine,26570,103,1.08 [0.87-1.33],0.4903669469813055
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27957,93,1.09 [0.87-1.36],0.4602435840281604
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Transient ischemic attack,27834,41,0.96 [0.68-1.35],0.7979012736977847
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other sleep disorders,26642,175,1.06 [0.90-1.25],0.4991401168823354
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Sleep apnoea,27703,136,1.00 [0.83-1.21],0.9609168734954384
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27183,621,1.04 [0.96-1.14],0.3405021992040746
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26700,138,1.07 [0.89-1.29],0.4606607854463407
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,26899,337,1.01 [0.90-1.14],0.8392065515369973
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28110,87,1.07 [0.85-1.35],0.5791811429022251
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Hemiplegia,28078,55,1.08 [0.81-1.45],0.5852819376823173
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Other neurological diseases,27895,126,0.92 [0.76-1.12],0.4032895110447355
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",27852,309,1.01 [0.89-1.14],0.8941668951688314
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27713,170,1.02 [0.86-1.21],0.8118496547687069
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27632,89,1.01 [0.80-1.27],0.9214141376729528
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27649,106,0.96 [0.77-1.18],0.6888765124569233
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27592,49,1.15 [0.85-1.57],0.3596766476748113
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26606,66,1.31 [1.01-1.71],0.0402857660515305
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26727,187,1.12 [0.95-1.31],0.1720225270085281
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27709,132,1.20 [0.99-1.44],0.0577054351106537
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28075,24,1.66 [1.11-2.49],0.0136433110024438
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1778,24,1.55 [1.02-2.36],0.0391656698793468
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26321,24,1.67 [1.12-2.50],0.0126773093668002
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27949,52,1.28 [0.96-1.72],0.0982378205554427
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,27926,29,1.13 [0.76-1.68],0.5524166699411397
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27861,96,0.94 [0.75-1.17],0.5579263328702628
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27906,98,1.05 [0.84-1.30],0.6750962304961468
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,28205,125,1.06 [0.87-1.28],0.5805458839780178
PPP1R2,Protein phosphatase inhibitor 2,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,27798,92,1.06 [0.84-1.32],0.6355604464796288
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22172,1992,1.06 [1.00-1.11],0.0503263978090093
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27999,39,0.69 [0.48-0.99],0.0425270362326433
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23240,1318,1.07 [1.00-1.14],0.0442161689714832
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertension,23264,1342,1.07 [1.00-1.14],0.0429654507743483
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,21973,51,1.01 [0.74-1.37],0.9526285689740416
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26796,577,0.94 [0.86-1.03],0.210086512966646
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Angina pectoris,26573,354,0.92 [0.81-1.03],0.1494273638026746
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27602,141,0.94 [0.78-1.13],0.496738603461801
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27728,267,0.92 [0.80-1.06],0.2389359741488067
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28218,60,0.89 [0.66-1.18],0.4089325445381404
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26384,165,0.93 [0.78-1.11],0.4176882156612619
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26638,430,0.92 [0.83-1.03],0.1402788990220434
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Pulmonary embolism,27815,83,1.19 [0.94-1.50],0.1500895198029022
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27800,176,1.06 [0.90-1.25],0.4598205250491424
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Secondary right heart disease,27796,64,1.08 [0.83-1.41],0.5731798573660918
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,27797,65,1.10 [0.84-1.43],0.4887635174254913
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",21983,61,1.09 [0.83-1.44],0.5321316164258453
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25645,47,0.78 [0.56-1.09],0.144797728361548
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Conduction disorders,25674,76,1.04 [0.81-1.33],0.7625707438660082
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19355,96,1.15 [0.92-1.43],0.2172906299784358
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19452,193,1.01 [0.87-1.19],0.8661957543720717
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other arrhythmias,25641,43,1.26 [0.91-1.74],0.1587595428492453
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25660,62,0.89 [0.67-1.18],0.4105564102425694
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27810,119,1.04 [0.85-1.27],0.7044063646460816
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",27786,115,0.99 [0.81-1.21],0.9180047841689658
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",27819,85,1.06 [0.84-1.34],0.6365629029720726
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",27868,75,1.08 [0.84-1.38],0.5526787064164818
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27584,52,1.08 [0.80-1.45],0.6233944286587854
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27614,82,1.02 [0.80-1.30],0.8691900978536404
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27082,114,1.10 [0.90-1.35],0.3429609003139617
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27063,95,1.15 [0.92-1.43],0.211565779131688
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28162,91,1.12 [0.90-1.41],0.3119678077000481
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Varicose veins,27408,440,0.87 [0.78-0.97],0.0093763617671569
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,Hypotension,27585,56,1.04 [0.78-1.39],0.7893616697386179
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,23969,1969,1.06 [1.01-1.12],0.0185700026630028
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28102,139,1.11 [0.93-1.33],0.2560588052132182
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27114,187,1.19 [1.02-1.40],0.0258145862319733
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27087,160,1.20 [1.01-1.42],0.0362217408673901
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27708,216,0.94 [0.81-1.09],0.4159298148253704
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27706,214,0.93 [0.80-1.08],0.3399176832704915
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27432,670,1.02 [0.94-1.11],0.5997541004052324
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic sinusitis,26859,97,1.20 [0.97-1.49],0.0965522200398113
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Nasal polyp,26872,110,1.05 [0.86-1.29],0.6250670493968165
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27196,434,1.04 [0.94-1.15],0.476488907897822
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Deviated nasal septum,26995,233,1.05 [0.92-1.21],0.4644717031975621
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16299,51,0.82 [0.60-1.13],0.2304318132743964
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,25926,895,1.05 [0.97-1.13],0.202230973141761
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Early onset COPD,27610,108,0.90 [0.72-1.13],0.37462046065949
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27610,108,0.90 [0.72-1.13],0.37462046065949
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27610,108,0.90 [0.72-1.13],0.37462046065949
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26536,815,1.05 [0.97-1.13],0.2328990798354457
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Asthma,21691,815,1.05 [0.97-1.14],0.1896296569186736
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21546,815,1.05 [0.97-1.14],0.1913065084023518
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21675,799,1.05 [0.97-1.13],0.2360880467980173
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28138,54,1.04 [0.77-1.40],0.8039110818821712
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Interstitial lung disease,26990,41,1.00 [0.71-1.40],0.9996611817549864
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28198,41,1.00 [0.71-1.41],0.994974104487136
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,26983,34,0.86 [0.59-1.26],0.4312609661248687
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Pleural effusion,26959,77,1.08 [0.84-1.38],0.5460001678658823
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other diseases of pleura,27062,180,1.13 [0.96-1.32],0.1444963197355193
PPP1R2,Protein phosphatase inhibitor 2,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27472,83,1.29 [1.02-1.63],0.0301900888445478
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20034,5179,1.02 [0.99-1.06],0.175060835231392
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27711,498,1.06 [0.96-1.16],0.2704103777471804
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28259,142,0.99 [0.83-1.19],0.9191365196700144
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Impacted teeth,28265,133,1.02 [0.85-1.23],0.8285265382081617
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Dental caries,27335,122,1.11 [0.92-1.35],0.2759861765042243
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27319,106,1.06 [0.86-1.30],0.5978617505336321
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28244,158,1.02 [0.86-1.21],0.8045780066192962
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27308,95,1.09 [0.87-1.36],0.4475538632716612
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27050,65,0.97 [0.74-1.27],0.8033041808578208
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28207,45,0.78 [0.56-1.08],0.1367798727411302
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,22763,203,0.96 [0.82-1.12],0.582377908764734
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24317,1757,1.03 [0.98-1.09],0.2969636594604583
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophagitis,22830,270,1.09 [0.95-1.24],0.2210820431926919
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23117,557,1.00 [0.91-1.10],0.9904487610020344
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22624,64,1.11 [0.85-1.45],0.4583404009280664
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22691,131,1.14 [0.94-1.37],0.1843084663659094
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22592,32,1.15 [0.79-1.69],0.4567999997098524
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Gastric ulcer,22661,101,1.03 [0.83-1.28],0.775497047553465
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Duodenal ulcer,22664,104,0.84 [0.67-1.05],0.1219428963483748
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28226,73,0.80 [0.62-1.05],0.1053203739649015
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Chronic gastritis,22661,101,0.91 [0.73-1.13],0.3838478175019381
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23209,649,1.06 [0.98-1.16],0.1622814668804104
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of appendix,28139,161,0.99 [0.84-1.18],0.9295446417997048
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Functional dyspepsia,22947,387,1.04 [0.93-1.16],0.4611696917735013
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22672,112,1.00 [0.81-1.22],0.967277879509394
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28126,190,0.97 [0.83-1.14],0.7041895407666656
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute appendicitis,28102,124,0.91 [0.74-1.10],0.3266830977662979
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Hernia,25527,1184,1.04 [0.97-1.11],0.2420201906950487
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Inguinal hernia,24741,398,1.00 [0.90-1.12],0.9570815187539052
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Umbilical hernia,24464,121,0.98 [0.80-1.20],0.8739825461209342
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ventral hernia,24437,94,0.84 [0.66-1.06],0.1325850941295336
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,24948,605,1.10 [1.01-1.21],0.0297564651021251
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27427,754,1.10 [1.02-1.19],0.0180965817744204
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestines,23317,1683,1.01 [0.95-1.06],0.8560042145847891
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",27991,73,1.09 [0.85-1.40],0.5147244731271625
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28247,102,1.11 [0.90-1.38],0.3236943017647498
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn disease,26775,102,1.12 [0.91-1.38],0.2995678937043834
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Crohn's disease NAS,26750,77,1.17 [0.92-1.49],0.211564553418975
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",28188,130,1.09 [0.90-1.31],0.3815659601880785
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Ulcerative colitis,26803,130,1.09 [0.90-1.32],0.361142676925278
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",26785,112,1.11 [0.91-1.36],0.3135148910371857
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27274,601,1.12 [1.03-1.22],0.0114511809928548
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27269,596,1.12 [1.03-1.23],0.0117977533416646
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21704,70,1.06 [0.82-1.37],0.6741627797640424
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal stricture,27987,70,1.05 [0.81-1.36],0.713586429979681
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21682,48,1.07 [0.79-1.47],0.6507627795375482
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,21943,309,1.06 [0.93-1.20],0.3670157949436761
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,21813,179,1.14 [0.97-1.33],0.1161132152351794
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21892,258,1.13 [0.99-1.30],0.0647649878186523
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Constipation,27128,231,1.11 [0.96-1.28],0.1618840105817045
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27897,78,1.01 [0.79-1.29],0.9258548715753426
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,21814,180,0.99 [0.84-1.17],0.9232432431032098
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21720,86,0.95 [0.75-1.21],0.69633011371438
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22429,795,0.99 [0.91-1.07],0.7531693180983662
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of intestine,21811,177,0.85 [0.72-1.00],0.0527297061007748
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27884,65,1.03 [0.79-1.35],0.8037626332013525
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of liver,27573,121,0.73 [0.60-0.90],0.0033355257678373
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of liver,27517,65,0.78 [0.59-1.03],0.0839122416924312
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27071,522,1.02 [0.93-1.12],0.6708386687106427
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholelithiasis,26961,412,1.01 [0.91-1.13],0.7915882778634412
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Cholecystitis,26630,81,1.19 [0.94-1.50],0.1487409605147799
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26594,45,0.99 [0.72-1.37],0.9651274583323468
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis,26609,60,0.83 [0.62-1.11],0.20604089983627
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),28154,60,0.83 [0.62-1.11],0.2011791702228299
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27049,291,1.07 [0.94-1.22],0.293551908777428
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Intestinal malabsorption,26825,67,1.01 [0.77-1.31],0.950001772312248
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Coeliac disease,26811,53,0.98 [0.73-1.32],0.8858198717021517
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",26801,43,1.14 [0.82-1.57],0.4456741674696908
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26945,187,1.12 [0.95-1.31],0.1680728218482575
PPP1R2,Protein phosphatase inhibitor 2,Chapter XI Diseases of the digestive system,GI-bleeding,26940,182,1.11 [0.94-1.30],0.2079744358861995
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25701,1507,0.97 [0.92-1.03],0.3084722836926541
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27939,103,1.05 [0.85-1.30],0.6327856032330745
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,27890,469,0.98 [0.88-1.08],0.6400296842632016
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27209,539,0.97 [0.88-1.06],0.4954943975833595
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27538,400,0.94 [0.85-1.06],0.3128373374068645
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27245,107,0.85 [0.69-1.06],0.1421295955169179
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27365,227,0.95 [0.82-1.09],0.4563716870272079
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28065,89,1.06 [0.84-1.33],0.6236475571612603
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28049,73,1.07 [0.83-1.37],0.6148476901428224
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28028,52,1.07 [0.79-1.44],0.658326887166345
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28156,36,0.87 [0.60-1.26],0.4514497683914289
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28153,33,0.88 [0.60-1.29],0.4990475712808325
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27486,65,1.09 [0.84-1.42],0.5261096589731789
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,27778,357,0.97 [0.86-1.08],0.5480993815905673
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26742,72,1.10 [0.85-1.41],0.4772962394436475
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,26769,99,0.83 [0.66-1.04],0.1003580454823396
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,26753,83,0.82 [0.64-1.05],0.1116252486927436
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",26884,214,0.96 [0.83-1.12],0.6400948172934883
PPP1R2,Protein phosphatase inhibitor 2,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,26856,186,0.92 [0.78-1.08],0.2898400654014514
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21916,3543,1.01 [0.97-1.05],0.8068311333671916
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23555,1873,1.00 [0.95-1.06],0.9388281643440736
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25864,1114,1.09 [1.02-1.16],0.0120199724135314
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,21799,117,1.17 [0.96-1.42],0.1208107062226577
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22022,340,1.04 [0.93-1.18],0.4761275887786845
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27983,112,1.17 [0.96-1.43],0.1286602941496525
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28000,100,1.14 [0.92-1.41],0.233327618011492
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22346,664,1.01 [0.92-1.10],0.8686589981882864
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",24974,664,1.01 [0.92-1.10],0.9004919496374713
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21728,46,1.16 [0.85-1.60],0.3464670382714605
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27934,45,1.16 [0.84-1.59],0.3758545845732928
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,21835,153,0.95 [0.79-1.13],0.5626281523840098
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21706,24,1.15 [0.75-1.79],0.5211529860962631
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,21806,124,0.97 [0.80-1.19],0.7945918903244006
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28215,59,0.95 [0.72-1.27],0.7468794900348315
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22013,331,1.01 [0.90-1.15],0.8136968545793347
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21909,227,1.00 [0.86-1.16],0.9866326164800794
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,22929,1247,0.98 [0.92-1.04],0.5159075461988871
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21720,38,1.02 [0.71-1.44],0.9321698972552508
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),21856,174,0.95 [0.80-1.12],0.5380381667884213
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21717,35,1.23 [0.86-1.76],0.2503211043669565
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21712,30,0.96 [0.65-1.44],0.8531399257604784
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22210,528,1.00 [0.91-1.10],0.9989774681879444
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22122,440,1.02 [0.92-1.13],0.7291066259991675
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22421,281,0.96 [0.84-1.09],0.5343187329327157
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,27928,147,0.95 [0.79-1.14],0.5684462029231627
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,27821,40,0.91 [0.64-1.28],0.5792622226381607
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25327,49,0.97 [0.71-1.32],0.8272110596063571
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25496,218,0.92 [0.79-1.06],0.2510434938451971
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26187,909,0.94 [0.87-1.01],0.096183821342993
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25415,137,1.02 [0.85-1.23],0.8167718467303444
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25333,55,0.71 [0.52-0.96],0.0265491934050152
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26045,767,0.95 [0.88-1.03],0.2024444238506014
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25336,58,0.86 [0.64-1.15],0.3164209423721106
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25532,254,1.03 [0.90-1.18],0.6682985518875701
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25392,114,1.06 [0.86-1.29],0.5979866968415334
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25348,70,0.83 [0.63-1.08],0.1656119284212875
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25430,152,0.91 [0.76-1.09],0.2981902801633629
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25346,68,1.01 [0.77-1.31],0.9604220593394264
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25602,324,1.05 [0.93-1.18],0.4765868110599619
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25037,287,1.00 [0.88-1.14],0.9720225790481996
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,24806,56,1.01 [0.75-1.35],0.9714873332943076
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,24804,54,0.98 [0.73-1.32],0.9006872698340754
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,24869,119,1.03 [0.84-1.26],0.7743957390863696
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",24808,58,1.00 [0.75-1.32],0.9758169420075432
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,24816,66,1.32 [1.02-1.71],0.032773795969095
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],24800,50,1.20 [0.89-1.62],0.2405152499881026
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,24976,226,0.98 [0.84-1.13],0.7468191743089745
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,24799,49,0.99 [0.72-1.35],0.9377248864614454
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,24804,54,0.99 [0.74-1.34],0.9715198990644976
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,24859,109,1.01 [0.82-1.24],0.95906498842717
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,24823,73,0.91 [0.71-1.18],0.4869160551444644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25183,433,1.16 [1.05-1.29],0.0048645726026281
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,24896,146,1.08 [0.90-1.29],0.4231870556543133
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,24974,224,1.23 [1.07-1.42],0.0037164111956038
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26929,99,0.97 [0.78-1.21],0.8015733066323351
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27174,344,0.91 [0.81-1.03],0.1319284143281022
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,26887,57,0.98 [0.73-1.31],0.8895337586550472
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,26900,70,0.88 [0.68-1.15],0.3430481701899344
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,26948,118,0.91 [0.74-1.11],0.3625229462730097
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,23957,4439,0.99 [0.95-1.03],0.5885531094104484
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11502,414,1.02 [0.91-1.13],0.7555851161671236
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26776,215,1.04 [0.90-1.21],0.613718527000799
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26618,57,1.03 [0.77-1.37],0.8648365862727954
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26928,46,1.13 [0.82-1.55],0.4535637938629245
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26932,50,1.13 [0.83-1.53],0.4461999020566167
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,26937,55,1.11 [0.83-1.48],0.4715808650771299
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27947,243,1.02 [0.89-1.18],0.7464833879871863
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28018,55,1.22 [0.91-1.62],0.1800566724058994
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27871,167,0.97 [0.82-1.15],0.7519339537928269
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,27803,99,1.17 [0.94-1.45],0.1567111793718801
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26793,887,0.94 [0.88-1.02],0.1345187950445853
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Cystitis,25990,84,0.88 [0.69-1.12],0.298324139716114
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,25972,66,1.05 [0.80-1.37],0.7455379637072059
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26090,184,0.99 [0.84-1.16],0.9083034255996328
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Urethral stricture,25995,89,0.98 [0.78-1.23],0.840175279877388
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26526,620,0.98 [0.89-1.07],0.6085073106119672
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11162,74,1.20 [0.94-1.53],0.1476009586372358
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11123,35,0.77 [0.53-1.13],0.1836618829548429
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Hydrocele,11125,37,1.00 [0.70-1.42],0.9886658299234916
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11181,93,1.20 [0.96-1.49],0.1048381950337278
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11154,66,1.15 [0.88-1.49],0.3072441276629534
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11193,105,0.83 [0.66-1.03],0.0858960108809494
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15476,254,1.03 [0.90-1.19],0.644883039841632
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15294,72,1.09 [0.85-1.41],0.4977914599495781
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15313,91,1.06 [0.84-1.33],0.6420770137662783
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15279,57,0.95 [0.71-1.27],0.7244512204092761
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15438,399,0.95 [0.85-1.06],0.3285121438027002
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,15122,83,0.90 [0.71-1.15],0.4180149784729221
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15235,196,1.00 [0.85-1.17],0.953640101918268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14229,2791,1.01 [0.97-1.06],0.6286248957992393
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Endometriosis,11736,298,1.13 [1.00-1.29],0.0583139604638655
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11527,89,1.27 [1.01-1.60],0.0386665338014974
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11556,118,1.11 [0.91-1.36],0.2953383814032899
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11748,310,1.05 [0.92-1.19],0.4784353914568279
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11737,299,0.94 [0.82-1.07],0.3302323014876308
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,11921,483,0.98 [0.88-1.08],0.6577676869715945
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11605,167,1.02 [0.86-1.21],0.8556844567471268
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11657,219,1.06 [0.91-1.23],0.4766965760776835
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11522,84,1.00 [0.79-1.28],0.968257676495139
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11577,139,1.14 [0.94-1.37],0.1763529969739644
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15626,200,1.19 [1.03-1.39],0.022666231779897
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15636,191,1.18 [1.01-1.38],0.0414435954553144
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15656,111,1.24 [1.01-1.52],0.0380245806487531
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15647,121,1.26 [1.04-1.53],0.0192505018128634
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11510,72,0.97 [0.75-1.26],0.8457477547666055
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11497,59,0.98 [0.73-1.30],0.8743225331056091
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11511,73,0.91 [0.70-1.18],0.4604933632334195
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Irregular menses,15550,379,1.12 [1.00-1.25],0.0505524954181956
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12588,1150,1.03 [0.96-1.10],0.4228112446819743
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12229,791,1.01 [0.93-1.09],0.8480931970293532
PPP1R2,Protein phosphatase inhibitor 2,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15635,156,1.05 [0.88-1.25],0.5736356406493193
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11795,357,0.95 [0.84-1.06],0.3527249158797575
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11720,282,0.95 [0.83-1.08],0.4321297298887364
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11706,268,1.06 [0.92-1.21],0.4324376136437589
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,Female infertility,11553,115,1.08 [0.88-1.33],0.4822012083746858
PPP1R2,Protein phosphatase inhibitor 2,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11546,108,1.05 [0.85-1.30],0.6590408997933781
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15651,877,0.99 [0.91-1.07],0.7228986133471116
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15656,1203,1.00 [0.93-1.08],0.9598979319066926
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15653,478,1.02 [0.92-1.13],0.746936860775675
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15310,135,0.94 [0.77-1.14],0.516706528931895
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15364,189,0.97 [0.82-1.14],0.7085698201409736
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15341,166,1.08 [0.90-1.28],0.4142358873627922
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15669,163,0.92 [0.77-1.09],0.3362117500979739
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15671,160,0.92 [0.77-1.09],0.3326303582010327
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15668,414,0.89 [0.79-1.00],0.0487327561292571
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15378,124,0.71 [0.58-0.88],0.0015749372507549
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15484,230,0.92 [0.79-1.07],0.3056132669482897
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,14920,146,1.02 [0.84-1.23],0.8749313461732076
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,14974,200,0.88 [0.75-1.04],0.1304064768088511
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,15022,248,0.95 [0.82-1.10],0.4687361667644099
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,14920,146,1.01 [0.84-1.22],0.9325967541677412
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,14912,138,1.01 [0.84-1.23],0.8841571934320095
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,14923,149,0.86 [0.71-1.04],0.1195899511603353
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14684,231,1.03 [0.89-1.20],0.7087488059018094
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],14887,434,0.97 [0.87-1.09],0.6581756848614466
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15126,673,1.02 [0.93-1.12],0.6467786903270443
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15673,170,1.05 [0.89-1.25],0.5525150858929495
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,14217,128,0.96 [0.79-1.18],0.7101108894252572
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14555,102,0.99 [0.79-1.24],0.9441324342788568
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15681,341,0.88 [0.78-1.00],0.0530348056153348
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15601,261,0.86 [0.74-0.99],0.0336283195703797
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15667,251,1.09 [0.94-1.26],0.2378045048769419
PPP1R2,Protein phosphatase inhibitor 2,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15658,242,1.10 [0.95-1.27],0.211444671539042
PPP1R2,Protein phosphatase inhibitor 2,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28075,37,1.05 [0.73-1.49],0.7966050829528493
PPP1R2,Protein phosphatase inhibitor 2,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26663,534,0.92 [0.84-1.02],0.1085140089043191
